Molecular Omics publishes high-quality research from across the -omics sciences that provide significant new insight into important chemical or biological problems.

Molecular Omics articles report research that significantly increases understanding or demonstrates clear functional benefits, supported by experimental validation or a novel data analytic approach.
Topics include, but are not limited to:

• omics studies to gain mechanistic insight into biological processes – for example, determining the mode of action of a drug or the basis of a particular phenotype, such as drought tolerance.

• omics studies for clinical applications with experimental validation, such as finding biomarkers for diagnostics or potential new drug targets.

• omics studies looking at the sub-cellular make-up of cells – for example, the subcellular localisation of certain proteins or post-translational modifications or new imaging techniques.

• studies presenting new methods and tools to support omics studies, including new spectroscopic/chromatographic techniques, chip-based/array technologies and new classification/data analysis techniques. New methods should be proven and demonstrate an advance in the field.

The following are not within the scope of Molecular Omics:

• Research based on reanalysis of public datasets without experimental validation and significant omics datasets.
• Papers without significant biological justification or interpretation.
• Research that is only of interest to the specialist in the area.
• Papers reporting new results that could be routinely predicted.
• Papers that do not show a significant improvement over known research.